Condition
Alzheimer's Disease Diagnosis
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Early P 1 (1)
Trial Status
Recruiting1
Enrolling By Invitation1
Not Yet Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07214974Early Phase 1Not Yet Recruiting
Mild Cognitive Impairment Community Screening and Early Intervention Via Stem Cell Therapy and Wearable Brain Computer Interface Device.
NCT06889896Enrolling By InvitationPrimary
Clinical Evaluation of Blood-Based Assays for Rapid Detection of Aβ Pathology in Alzheimer's Disease
NCT05020626RecruitingPrimary
Modelling Tau Distribution From DTI With Generative Adversarial Network for Alzheimer's Disease Diagnosis
Showing all 3 trials